Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance.

Am J Kidney Dis

Division of Nephrology, Department of Internal Medicine, Saint Louis University, St. Louis, MO. Electronic address:

Published: December 2017

Gabapentin is almost exclusively cleared by the kidney and thus presents challenges in patients with kidney failure. Gabapentin is known to be effectively cleared by hemodialysis, but the efficiency of clearance by peritoneal dialysis (PD) has not been previously described. We report a case of gabapentin toxicity in a patient on long-term PD who was treated with continuous automated cycling PD. We find that continuous PD provides significant clearance of gabapentin. With 2-L exchanges every 2 hours, we document an apparent elimination half-life of 41.33 hours, which is substantially shorter than the reported elimination half-life of 132 hours in the absence of kidney function. Further, our patient's symptoms of gabapentin toxicity gradually improved and had fully resolved after about 36 hours of dialysis. Gabapentin clearance by PD was estimated at 94% of urea clearance. We conclude that intensive PD provides gabapentin clearance that approximates that of urea and is an effective but slow method to treat gabapentin overdose and toxicity.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2017.05.010DOI Listing

Publication Analysis

Top Keywords

gabapentin toxicity
12
gabapentin clearance
12
gabapentin
9
peritoneal dialysis
8
clearance gabapentin
8
elimination half-life
8
clearance
6
treatment gabapentin
4
toxicity
4
toxicity peritoneal
4

Similar Publications

Peripheral nerve injuries (PNIs) are common, costly, and cause significant pain. Effective management of PNIs involves tailoring medications to the injury type as well as understanding the pharmacokinetics/pharmacodynamics to support nerve regeneration and reduce pain. Opioids act on opioid receptors to significantly reduce pain for many patients, but there are significant addiction risks and side effects.

View Article and Find Full Text PDF

Background: Gabapentin and pregabalin were originally introduced as anticonvulsant medications but are now also prescribed on- and off-label for multiple medical disorders, especially for pain management. The national opioid crisis has led to increased use of non-opioid pain medications, including gabapentinoids, which has been associated with changing patterns of adverse events associated with these medications. This study investigated the characteristics and trends of gabapentin and pregabalin exposures reported to US poison centers from 2012 to 2022.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the neuroprotective effects of methanol extracts from two edible medicinal plants, Salix tetrasperma and Plantago asiatica, against rotenone-induced neurotoxicity in SH-SY5Y cells.
  • Both plant extracts demonstrated antioxidant properties by reducing oxidative stress and improving survival of neurons affected by rotenone through various assays.
  • LC-QTOF-MS analysis identified compounds with neuroprotective potential, suggesting these plants could be valuable sources for developing herbal nutraceuticals aimed at treating neurodegenerative diseases, such as Parkinson's.
View Article and Find Full Text PDF

Inhibition of soluble epoxide hydrolase (sEH) is a promising therapeutic strategy for treating neuropathic pain. These inhibitors effectively reduce diabetic neuropathic pain and inflammation induced by Freund's adjuvant which makes them a suitable alternative to traditional opioids. This study showcased the notable analgesic effects of compound (1,1'-(hexane-1,6-diyl)bis(3-((adamantan-1-yl)methyl)urea)) in both inflammatory and diabetic neuropathy models.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!